Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

China Kadoorie Biobank

Logo

Founded in 2004

510,000 participants

From 10 regions of China

8 years of follow-up data

The China Kadoorie Biobank (CKB) is set up to investigate the main genetic and environmental causes of common chronic diseases in the Chinese population.

During 2004-8, over 510,000 adults were recruited from 10 geographically defined regions of China, with extensive data collection by questionnaire and physical measurements, and with long-term storage of blood samples for future study. All the participants are now being closely monitored for death and other health-related outcomes through linkage with established registries and health insurance databases in the study areas.

The China Kadoorie Biobank (CKB) is a powerful resource for investigating the main causes of many common chronic diseases, and the information generated will advance our understanding of disease aetiology in China and in other countries.

The CKB is being conducted jointly by the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in the Nuffield Department of Population Health, University of Oxford and the Chinese Academy of Medical Sciences. It is led by an International Steering Committee. Professor Zhengming Chen in Oxford and Professor Liming Li in Beijing are the study’s principal investigators.

CKB was established with funding support to CTSU from the Kadoorie Charitable Foundation in Hong Kong. The long-term continuation of the study is supported by Wellcome, with further support in China from the Chinese Natural Science Foundation and Chinese Ministry of Science and Technology. The UK Medical Research Council, British Heart Foundation and Cancer Research UK also provide core funding to CTSU for the project.

Visit the study website

If you are interested in accessing data from CKB, please visit the CKB Data Access webpages 

NDPH Data Access Policy

 

 

Our team

Funding

Kadoorie Charitable Foundation

Wellcome 

Medical Research Council

Cancer Research UK

British Heart Foundation

Selected publications

Related research themes

Prospective Studies
Prospective Studies
Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease, angina, heart attack, congenital heart disease and stroke. Despite improvements in the prevention and treatment of CVD in recent decades, it remains the leading cause of death worldwide, particularly in developed countries.
Cardiovascular Disease
The link between smoking and lung cancer was originally discovered by Sir Richard Doll in 1956. Sir Richard Peto has continued to study the impact of tobacco of global health (see video). Smoking cigarettes is a leading cause of premature death worldwide. There were about 100 million deaths from tobacco in the 20th century, most in developed countries. If current smoking patterns persist, it is estimated that tobacco will kill about 1 billion people this century, mostly in low- and middle-income countries, and about half of these deaths will occur before age 70.
Smoking
Diabetes Mellitus is a group of metabolic disorders in which there are high blood sugars over a prolonged period. Rates of type-2 (or adult onset) diabetes have increased rapidly in recent decades due to changes in diet and other lifestyle factors. Patients with diabetes are at increased risk of a number of diseases, most notably cardiovascular disease, kidney disease and damage to the eyes.
Diabetes Mellitus
The Global Burden of Disease 2010 study attributed more deaths to high blood pressure than to any other risk factor. Blood pressure is a well-established risk factor for vascular disease, but important questions remain about its importance in different patient groups and for different clinical outcomes.
Blood Pressure
Chronic disease is responsible for a major part of our society’s burden of disability. In addition to our research into chronic diseases such as cancer, cardiovascular disease, diabetes and renal disease we conduct a range of research into other diseases, as well as into the care of people with chronic conditions.
Other Chronic Diseases